Enzychem Lifesciences Corporation

Enzychem Lifesciences Corporation

Share · KR7183490002 (XKOS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Enzychem Lifesciences Corporation
No Price
Share Float & Liquidity
Free Float 77,65 %
Shares Float 59,8 M
Shares Outstanding 77,01 M
Invested Funds

The following funds have invested in Enzychem Lifesciences Corporation:

Fund
iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF USD (Dist)
Vol. in million
63,39
Percentage (%)
0,06 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Dist)
Vol. in million
20,02
Percentage (%)
0,0064 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Acc)
Vol. in million
101,33
Percentage (%)
0,0064 %
Company Profile for Enzychem Lifesciences Corporation Share
Enzychem Lifesciences Corporation, a pharmaceutical company, focuses on the development of oral small molecule therapies for patients with unmet medical needs for oncology, metabolic diseases, and inflammatory diseases in South Korea. It is also developing potential therapies based on EC-18 technology platform to treat chemotherapy-induced neutropenia, chemoradiation therapy-induced oral mucositis, and acute radiation syndrome. The company was founded in 1999 and is headquartered in Seoul, South Korea.

Company Data

Name Enzychem Lifesciences Corporation
Company Enzychem Lifesciences Corporation
Website http://www.enzychem.com
Primary Exchange XKOS KOSDAQ
ISIN KR7183490002
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Ki-Young Sohn
Market Capitalization 76 Mrd.
Country South Korea
Currency KRW
Employees 0,1 T
Address aT Center, Seoul
IPO Date 2017-04-05
Dividends from 'Enzychem Lifesciences Corporation'
Ex-Date Dividend per Share
15.03.2022 1,71 KRW

Stock Splits

Date Split
17.08.2022 6:1
25.10.2021 253:200

Ticker Symbols

Name Symbol
KOSDAQ 183490.KQ
More Shares
Investors who hold Enzychem Lifesciences Corporation also have the following shares in their portfolio:
Harding Loevner Institutional Emerging Markets Portfolio
Harding Loevner Institutional Emerging Markets Portfolio Fund
US Treasury 6 Month Bill ETF
US Treasury 6 Month Bill ETF ETF